A pharmacokinetic phase I study to assess the effect of different application sites on the pharmacokinetics of testosterone from a Testosterone Metered Dose (MD) Lotion in hypogonadism.
Phase 1
Completed
- Conditions
- HypogonadismMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12605000518662
- Lead Sponsor
- Acrux DDS Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 12
Inclusion Criteria
Healthy female volunteers
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method